feed,title,long_url,short_url
Benzinga,Peloton Rolls Out Extended Free Trial Period: Will It Stop COVID Lockdown Stock's Downhill Slide?,https://benzinga.com/trading-ideas/long-ideas/22/03/25993401/peloton-rolls-out-extended-free-trial-period-will-it-stop-covid-lockdown-stocks-downhill,https://bit.ly/3vAGBw9
Benzinga,Cantor Fitzgerald Cuts ADC Therapeutics Price Target On 'Repositioned Zynlonta Pipeline Strategy',https://benzinga.com/general/biotech/22/03/25991030/cantor-fitzgerald-cuts-adc-therapeutics-price-target-on-repositioned-zynlonta-pipeline-strategy,https://bit.ly/3KdIOBC
Benzinga,Analysts Move To Sidelines On Vicarious Surgical After Regulatory Update,https://benzinga.com/news/earnings/22/03/25993842/analysts-move-to-sidelines-on-vicarious-surgical-after-regulatory-update,https://bit.ly/34e9t1X
